Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Patent
1993-12-07
1997-01-14
Wityshyn, Micheal G.
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
435 701, 435 702, 435 7021, 4352402, 43524026, 43524027, 4352403, A01N 102, C12P 2104, C12N 500
Patent
active
055938221
ABSTRACT:
A method for preparing serum depleted of IgG to be used in the production of IgG monoclonal antibodies is disclosed. Animal serum is contacted with protein G or protein A prior to addition to base media to obtain a superior cell culture medium depleted of serum derived IgG antibodies. Included in the disclosure are improved media preparations for cell culture of antibody producing cells and incorporating the antibody depleted serum and improved methods of producing the antibodies.
REFERENCES:
patent: 4704366 (1987-11-01), Juarez-Salinas et al.
patent: 4714556 (1987-12-01), Ambrus et al.
patent: 5273884 (1993-12-01), Gale et al.
Wyatt et al, Adv. Anim. Cell. Biol. Technol. Bioprocesses (270-72) 1989.
Fujimoto et al., American Biotechnology Laboratory, 9(2) p. 54 (Mar. 1991).
Advanced Protein Products, Trends in Biotechnology, 5 (7) p. 187 (Jul. 1987) (see abstract).
Hy Clone, Product & Services Guide for the Cell Culture Scientists p. 6-13 (1993).
Savelkoul et al., J. of Immunological Methods, vol. 172, pp. 33-42 (1994).
Cole, S. P. C. et al., "Anitbody Production by Human Hybridomas in Serum-Free Medium," J. of Immunol. Methods, 78:271-278 (1985).
Darby, C. R., et al., "Purification of monoclonal antibodies from tissue culture medium depleted of IgG," J. Immunol. Methods, 159:125-129 (1993).
Glassy, M. C., et al., "Serum-Free Media in Hybridoma Culture and Monoclonal Antibody Production," Biotech. and Bioeng., 32:1015-1028 (1988).
Heath, C., et al., "Methods for increasing monoclonal anitbody production in suspension and entrapped cell cultures: biochemical and flow cytometric analysis as a function of medium serum content," J. Biotechnol., 15:71-90 (1990).
Jiskoot, W., et al., "Two-step purification of a murine monoclonal antibody intended for therapeutic application in man," J. Immunol. Methods, 124:143-156 (1989).
MacLeod, A. J. et al., "Use of Plasma Protein Fractions as Serum Substitutes for In Vitro Cell Culture," Develop. Biol. Standard., 60:55-61 (1985).
Mariani, E., et al., "Commercial serum-free media: hybridoma growth and monoclonal antibody production," J. Immunol. Methods, 145:175-183 (1991).
Patel, T. P., et al., "Different culture methods lead to differences in glycoslation of a murine IgG monoclonal antibody," Biochem. J., 285:839-845 (1992).
Schneider, Y-J., "Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined, serum-and protein- free culture medium," J. Immunol. Methods, 116:65-77 (1989).
Trends in Biotechnology, 5(7):187, Jul., 1987.
Irie Reiko F.
Zeng Qing S.
Dadio Susan M.
John Wayne Cancer Institute
Wityshyn Micheal G.
LandOfFree
IgG depleted serum preparations and methods for antibody product does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IgG depleted serum preparations and methods for antibody product, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IgG depleted serum preparations and methods for antibody product will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1387177